Design
Review
Authors
Loading...
Supports preclinical renin inhibition; leaves open clinical translation without randomized human trials.
This review outlines the development and potential of four classes of renin inhibitors, highlighting their efficacy in reducing the hypertensive effects of renin in vivo.
Edgar Haber (1983) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: